NCT00663325 Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet Flower Status COMPLETED Phase PHASE3
NCT00663273 Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet Flower Status COMPLETED Phase PHASE3
NCT00662870 Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine Status COMPLETED Phase PHASE3
NCT00659477 Comparison Safety and Efficacy of Basal Insulin Lantus® (Insulin Glargine) vs NPH Insulin in Combination With Oral Antidiabetic Drugs (OADs) in Patients With Diabetes Mellitus, Type 2 (DMT2) Status COMPLETED Phase PHASE4
NCT00653848 Adjuvant Treatment of Prostate Cancer With Docetaxel or Not After Radical Radiotherapy Status UNKNOWN Phase PHASE3
NCT00653341 Effect of Insulin Glargine in Insulin Naïve Subjects With Type 2 Diabetes on Oral Hypoglycemic Agent(s) Status COMPLETED Phase PHASE3
NCT00653302 Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine) Status COMPLETED Phase PHASE4
NCT00648453 Effect of Plavix on NO (Nitrogen Monoxide) Production of the Endothelial Function Status COMPLETED Phase PHASE4
NCT00646438 United States Coronary Artery Bypass Surgery (CABG) Diabetes Project (USCDP) Pilot Study Status UNKNOWN Phase NA
NCT00644124 Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell Lymphoma Status COMPLETED Phase PHASE1
NCT00642915 Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil) Status COMPLETED Phase PHASE4
NCT00638859 Japanese Study Evaluating the Effects of Telithromycin in Children With Community-Acquired Pneumonia Status COMPLETED Phase PHASE3
NCT00638534 Japanese Study Evaluating the Effects of Telithromycin in Children With Acute Otitis Media Status COMPLETED Phase PHASE3
NCT00638118 Fexofenadine HCl 180 mg, Montelukast Sodium 10 mg and Placebo in Suppression of Wheal and Flare Induced by Seasonal Allergen Status COMPLETED Phase PHASE4
NCT00637884 A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study Designed to Evaluate the Efficacy of Fexofenadine HCl 180 mg for Preventing and Controlling Cat Allergy Symptoms Status COMPLETED Phase PHASE4
NCT00637611 Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure Unit Status COMPLETED Phase PHASE4
NCT00637585 Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by Histamine Status COMPLETED Phase PHASE4